Polymyositis in a child with thalassemia after hematopoietic stem cell transplantation
Authors:
- Yonghong TanYTYonghong Tan
- Jinzong LinJLJinzong Lin
- Xiuli HongXHXiuli Hong
- Jingyuan LuJLJingyuan Lu
- Quanyi LuQLQuanyi Lu
Open Access
- 15 October 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (41) , e27388
Abstract
Rationale: Polymyositis (PM) is a rare neuromuscular phenotype of chronic graft-versus-host disease (cGVHD). Although glucocorticoids have been shown to be effective in the treatment of PM, most people experience poor treatment response and poor prognosis. Patient concerns: A six-year-old boy with thalassemia received allogeneic hematopoietic stem cell transplantation (HSCT) and consequently developed sudden myasthenia of limbs 17 months after the transplant. Diagnoses: Medical history, current symptoms, laboratory examinations, and imaging findings of the patient indicated cGVHD complicated with PM. Interventions: He was then given high-dose corticosteroid therapy, including tacrolimus, ruxolitinib, and rituximab. Outcomes: Twenty-three months after transplantation, creatine kinase levels returned to normal range, and the MRI showed that the original muscle edema signal was significantly improved. The patient's muscle weakness continued to improve, and his overall condition was good. Lessons: This report suggests that glucocorticoids combined with immunosuppressants may be effective against polymyositis. Rituximab and ruxolitinib may be a good choice in treating polymyositis.Keywords
All Related Versions
Funding Information
- Scientific Research Program of Xiamen (3502Z20209024)
- Scientific Research Program of Xiamen (2019D009)
This publication has 28 references indexed in Scilit:
- A novel conditioning regimen improves outcomes in β-thalassemia major patients using unrelated donor peripheral blood stem cell transplantationBlood, 2012
- Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host diseaseBlood, 2011
- Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host diseaseBrain, 2010
- Evaluation and treatment of inflammatory myopathiesJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCTBone Marrow Transplantation, 2008
- Polymyositis – An unusual presentation of cGvHD in childrenPediatric Transplantation, 2006
- Acute polymyositis after donor lymphocyte infusionEuropean Journal of Haematology, 2005
- Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentationBone Marrow Transplantation, 2002
- Chronic graft-versus-host disease: is there an alternative to the conventional treatment?Bone Marrow Transplantation, 2000
- Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-diseaseBone Marrow Transplantation, 1999